Winncare, a leading European manufacturer of beds, pressure care products, patient handling equipment, and hygiene solutions has acquired Herida Medical, strengthening its pressure area care portfolio and providing entry into the maintenance and decontamination market. The acquisition was completed on November 30th 2022.
Herida Medical, based in Leeds, has built a successful mattress range having launched the highly regarded Avon brand and developing two of the leading dynamic systems in the Argyll and Pure Air range of mattresses. Employing more than 70 staff, the business supplies healthcare organisations in the UK and export markets including Australia. The company has demonstrated a consistent and solid growth over the past years and is expected to exceed £14.5M in revenues this year.
Laurent Faugere, President of Winncare Group said: “The acquisition of Herida Medical continues to position Winncare as a leading provider of innovative healthcare solutions that improve outcomes for dependent people. Herida joins Winncare Group as our second UK acquisition, and we are excited about the opportunities for growth the combined expertise will deliver. Our focus is on supplying quality products that add value for our customers and clinicians, both in the UK and through our export markets. The additional manufacturing capabilities the acquisition brings strengthen and extend the services Winncare are able to offer in the UK and our combined portfolio means we can deliver an unrivalled solutions-based approach to pressure care management.”
Simon Claridge, current Winncare UK CEO, will head the combined UK business, supported by Herida’s managing director, Sean Spencer. Simon says, “Winncare has ambitious growth plans in the UK and globally. The acquisition delivers business synergies both commercially and within the supply chain, which will enhance the service we offer our customers. The Winncare team is excited to talk about the new product portfolio with our clients and introduce the decontamination service to new customers.”
Herida’s managing director Sean Spencer, who is continuing in his role, says: “The acquisition by Winncare marks the start of an exciting new era for our business. Over the last few years, we have spent time appointing the right people and the right teams in order to grow and with the strength of Winncare behind us, there is the opportunity to escalate this further. I predict a very bright future for us in the pressure area care sector.”
With this acquisition, the Group continues to reinforce its footprint in the UK and to complement its broad and competitive product portfolio. This M&A operation perfectly aligns with the strategy of the group initiated by Siparex (a leading French independent private equity investment company), who took a majority stake in the company back in 2021. It is also the first M&A operation since the new President, Laurent Faugère (former CEO of Urgo Medical), joined the group earlier this year. After the acquisition of PharmaOuest last year and now with the acquisition of Herida Medical, Winncare Group reinforces its leadership on the European market with 5 affiliates, 9 production sites and a broad network of specialist medical distributors to distribute its product in more than 75 countries.
Alexandre Tremblin and Guillaume Rebaudet, Partners at Siparex, said: With the acquisition of Herida Medical, Winncare has doubled its revenues since we joined back in 2021 to achieve €140M in revenues. We take advantage of this operation to reinvest in the company and further support the upcoming growth journey we anticipate, both organically and through other acquisitions to keep consolidating the market in the next months”.
For further information email Clare Birt, Marketing Director at email@example.com or call 01544 262002.